GENinCode (GENI)

Sector:

Health Care

Index:

FTSE AIM All-Share

 2.30p
   
  • Change Today:
      0.000p
  • 52 Week High: 5.80
  • 52 Week Low: 1.40
  • Currency: UK Pounds
  • Shares Issued: 286.88m
  • Volume: 0
  • Market Cap: £6.60m

Regulatory News

Publication of Landmark Study in JACC: Advances 27-Oct-2025 07:00 RNS
Holding(s) in Company 13-Oct-2025 16:21 RNS
Half-year Report 30-Sep-2025 07:00 RNS
NHS (UCLH) Risk of Ovarian Cancer (ROCA) launch 25-Sep-2025 07:00 RNS
Holding(s) in Company 24-Sep-2025 17:58 RNS
Stmnt re Share Price Movement 17-Sep-2025 10:42 RNS
Notice of Results 05-Sep-2025 07:00 RNS
Trading update 26-Aug-2025 07:00 RNS
De Novo Update – FDA Supervisory Review 07-Jul-2025 07:00 RNS
Result of AGM 30-Jun-2025 11:42 RNS
Final Results 04-Jun-2025 07:00 RNS
Notice of Results 16-May-2025 07:00 RNS
De Novo Submission Update 30-Apr-2025 07:00 RNS
Grant of Share Options & PDMR Dealings 26-Mar-2025 07:45 RNS
Holding(s) in Company 06-Mar-2025 14:24 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

GENinCode Market Data

Currency UK Pounds
Share Price 2.30p
Change Today 0.000p
% Change 0.00 %
52 Week High 5.80
52 Week Low 1.40
Volume 0
Shares Issued 286.88m
Market Cap £6.60m

GENinCode Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.88% below the market average61.88% below the market average61.88% below the market average61.88% below the market average61.88% below the market average
3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average
Price Trend
96.03% below the market average96.03% below the market average96.03% below the market average96.03% below the market average96.03% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average
Income Not Available
Growth
48.97% above the market average48.97% above the market average48.97% above the market average48.97% above the market average48.97% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

GENinCode Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

GENinCode Key Personnel

CEO Matthew Heaton Walls
CFO Paul Andrew Peter Foulger
COO Jordi Puig Gilberte

Top of Page